Matta, Hittu <br/><br/>
The proteasome inhibitor bortezomib (PS-341) inhibits growth and induces apoptosis in primary effusion lymphoma cells.  [electronic resource] 

 -  Cancer biology & therapy  Jan 2005 
 - 77-82 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1538-4047 
<br/><br/><label>Standard No.: </label>10.4161/cbt.4.1.1379  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Apoptosis<br/>Boronic Acids--pharmacology<br/>Bortezomib<br/>Cell Proliferation--drug effects<br/>Herpesviridae Infections--complications<br/>Herpesvirus 8, Human--pathogenicity<br/>Humans<br/>Lymphoma, Non-Hodgkin--pathology<br/>Pyrazines--pharmacology<br/>Tumor Cells, Cultured